Find disease awareness content and relevant supporting materials

This 2025 EULAR update provides evidence‑based recommendations on physical activity for people with inflammatory arthritis and osteoarthritis. It supports safe, tailored exercise to improve physical function, symptoms, and overall health.

This AASM clinical practice guideline provides evidence‑based recommendations for evaluating and managing obstructive sleep apnea in adults hospitalized for medical care. It addresses inpatient assessment, diagnostic pathways, and treatment strategies to improve outcomes in acute care settings.

This AASM clinical practice guideline provides evidence‑based recommendations for the treatment of central sleep apnea in adults. It outlines therapeutic options, including ventilation strategies and device‑based treatments, to improve sleep quality and clinical outcomes.

These Canadian guidelines provide evidence‑based recommendations for diagnosing obstructive sleep apnea in children. They outline clinical assessment, use of sleep studies, and diagnostic pathways to support timely and accurate identification in paediatric populations.

This WHO guideline provides evidence‑based recommendations for the clinical treatment of tobacco cessation in adults. It covers behavioural support, pharmacological therapies, and implementation considerations to improve quit outcomes across healthcare settings.

This second part of the Polish Psychiatric Association recommendations focuses on the management of nicotine dependence in patients with psychiatric disorders. It builds on Part I by addressing therapeutic strategies and clinical considerations to support effective smoking cessation in this population.

These recommendations from the Polish Psychiatric Association address the management of nicotine dependence in patients with psychiatric disorders. They focus on assessment, clinical considerations, and evidence‑based approaches to support smoking cessation in this vulnerable population.

These ATS recommendations provide evidence‑based guidance on treating nicotine use in adolescents under 18 years of age. They address behavioural interventions, pharmacotherapy considerations, and clinical strategies to support cessation in young people.

These Canadian recommendations provide evidence‑based guidance on interventions to support tobacco smoking cessation in adults. They address behavioural strategies, pharmacotherapy options, and clinical approaches to improve quit rates and long‑term abstinence.

This 2025 ACR guideline provides updated, evidence‑based recommendations for the treatment of systemic lupus erythematosus. It addresses therapeutic strategies across disease manifestations, including immunomodulatory and biologic therapies, with a focus on optimising outcomes and supporting patient‑centred care.